0000899243-20-011989.txt : 20200505 0000899243-20-011989.hdr.sgml : 20200505 20200505061509 ACCESSION NUMBER: 0000899243-20-011989 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200501 FILED AS OF DATE: 20200505 DATE AS OF CHANGE: 20200505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STEPHENSON BRIAN C CENTRAL INDEX KEY: 0001780030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38959 FILM NUMBER: 20846734 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-01 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001780030 STEPHENSON BRIAN C C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 See Remarks Common Stock 2020-05-01 4 S 0 6000 29.1133 D 324316 D Common Stock 2020-05-01 4 S 0 1200 29.8288 D 323116 D Common Stock 2020-05-04 4 S 0 1494 30.0048 D 321622 D This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2019. Represents the weighted average sale price of the shares sold from $28.71 to $29.68 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 4. Represents the weighted average sale price of the shares sold from $29.71 to $30.14 per share. Represents the weighted average sale price of the shares sold from $30.00 to $30.02 per share. Secretary, Treasurer and Chief Financial Officer /s/ Tara Condon, Attorney-in-Fact 2020-05-04